 Jennifer Matsuda
Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Killer Cells, Natural | 15 | 2018 | 427 | 1.800 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 14 | 2024 | 336 | 1.220 |
Why?
| | Natural Killer T-Cells | 7 | 2016 | 65 | 1.010 |
Why?
| | Antigens, CD1 | 8 | 2008 | 58 | 0.970 |
Why?
| | T-Lymphocyte Subsets | 6 | 2022 | 412 | 0.870 |
Why?
| | Antigens, CD1d | 14 | 2018 | 66 | 0.800 |
Why?
| | Cell Differentiation | 9 | 2018 | 1887 | 0.650 |
Why?
| | Transcription Activator-Like Effector Nucleases | 1 | 2016 | 6 | 0.520 |
Why?
| | Cell Movement | 5 | 2020 | 944 | 0.510 |
Why?
| | T-Lymphocytes | 8 | 2025 | 1933 | 0.500 |
Why?
| | Th1 Cells | 2 | 2007 | 137 | 0.460 |
Why?
| | Lymphocyte Activation | 8 | 2022 | 1109 | 0.450 |
Why?
| | Mice | 35 | 2025 | 16915 | 0.430 |
Why?
| | Mice, Inbred C57BL | 22 | 2024 | 5439 | 0.420 |
Why?
| | Antigen Presentation | 3 | 2018 | 207 | 0.410 |
Why?
| | Thymus Gland | 7 | 2024 | 308 | 0.390 |
Why?
| | Galactosylceramides | 6 | 2010 | 23 | 0.370 |
Why?
| | Animals | 40 | 2025 | 35307 | 0.350 |
Why?
| | Immune Tolerance | 2 | 2025 | 355 | 0.340 |
Why?
| | Major Histocompatibility Complex | 2 | 2024 | 230 | 0.330 |
Why?
| | T-Box Domain Proteins | 3 | 2007 | 96 | 0.330 |
Why?
| | Models, Immunological | 2 | 2007 | 95 | 0.330 |
Why?
| | CD4-Positive T-Lymphocytes | 6 | 2024 | 1056 | 0.330 |
Why?
| | Histocompatibility Antigens Class II | 3 | 2016 | 363 | 0.330 |
Why?
| | Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 4 | 2012 | 21 | 0.320 |
Why?
| | Interferon-gamma | 4 | 2015 | 772 | 0.310 |
Why?
| | Antigens | 5 | 2020 | 356 | 0.300 |
Why?
| | Lymphocyte Subsets | 2 | 2005 | 84 | 0.290 |
Why?
| | Mutation | 4 | 2020 | 3710 | 0.280 |
Why?
| | Mice, Knockout | 11 | 2020 | 2871 | 0.270 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 2 | 2022 | 100 | 0.260 |
Why?
| | HLA-DRB1 Chains | 1 | 2025 | 108 | 0.230 |
Why?
| | Autoantigens | 2 | 2011 | 419 | 0.220 |
Why?
| | NADPH Oxidases | 1 | 2024 | 108 | 0.210 |
Why?
| | Genes, T-Cell Receptor alpha | 1 | 2003 | 12 | 0.210 |
Why?
| | Catecholamines | 1 | 2023 | 96 | 0.210 |
Why?
| | Phagocytes | 1 | 2024 | 97 | 0.210 |
Why?
| | Methionine | 1 | 2024 | 156 | 0.210 |
Why?
| | Transcription Factors | 3 | 2005 | 1647 | 0.210 |
Why?
| | Glutamic Acid | 1 | 2025 | 235 | 0.200 |
Why?
| | Antigens, Differentiation, B-Lymphocyte | 1 | 2002 | 37 | 0.200 |
Why?
| | Collagen | 1 | 2025 | 433 | 0.200 |
Why?
| | Interleukin-4 | 1 | 2003 | 212 | 0.200 |
Why?
| | Interleukin-15 | 1 | 2002 | 82 | 0.190 |
Why?
| | Dendritic Cells | 3 | 2020 | 479 | 0.190 |
Why?
| | Th2 Cells | 1 | 2003 | 171 | 0.190 |
Why?
| | Adipocytes | 1 | 2023 | 204 | 0.190 |
Why?
| | Histone Deacetylases | 1 | 2023 | 212 | 0.190 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2023 | 209 | 0.190 |
Why?
| | Colitis | 2 | 2002 | 241 | 0.180 |
Why?
| | Casein Kinase II | 1 | 2020 | 21 | 0.180 |
Why?
| | Dermis | 1 | 2020 | 31 | 0.170 |
Why?
| | Signal Transduction | 4 | 2020 | 4926 | 0.170 |
Why?
| | Listeriosis | 1 | 2020 | 67 | 0.170 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 2020 | 23 | 0.170 |
Why?
| | Immunity | 1 | 2020 | 138 | 0.160 |
Why?
| | Gene Expression Regulation | 3 | 2013 | 2537 | 0.160 |
Why?
| | Listeria monocytogenes | 1 | 2020 | 123 | 0.160 |
Why?
| | Myeloid Cells | 1 | 2020 | 141 | 0.160 |
Why?
| | Respiratory Hypersensitivity | 2 | 2010 | 64 | 0.150 |
Why?
| | B7-H1 Antigen | 1 | 2020 | 195 | 0.150 |
Why?
| | Immunologic Memory | 1 | 2020 | 349 | 0.150 |
Why?
| | Mice, Transgenic | 6 | 2025 | 2117 | 0.140 |
Why?
| | Autoimmunity | 2 | 2020 | 862 | 0.140 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 455 | 0.140 |
Why?
| | Glycolipids | 1 | 2018 | 42 | 0.140 |
Why?
| | Mice, Inbred BALB C | 4 | 2018 | 1247 | 0.140 |
Why?
| | Lipids | 1 | 2001 | 625 | 0.140 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2016 | 27 | 0.130 |
Why?
| | Down Syndrome | 1 | 2023 | 477 | 0.130 |
Why?
| | B-Lymphocytes | 1 | 2022 | 815 | 0.130 |
Why?
| | Growth Differentiation Factor 15 | 1 | 2016 | 41 | 0.130 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2016 | 373 | 0.130 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 757 | 0.130 |
Why?
| | Arthritis, Rheumatoid | 1 | 2025 | 1097 | 0.130 |
Why?
| | Inflammation | 3 | 2020 | 2737 | 0.120 |
Why?
| | Epithelial Cells | 3 | 2020 | 1063 | 0.120 |
Why?
| | Fibroblasts | 1 | 2020 | 947 | 0.120 |
Why?
| | Cellular Senescence | 1 | 2016 | 181 | 0.120 |
Why?
| | Pseudomonas Infections | 1 | 2016 | 221 | 0.110 |
Why?
| | Pseudomonas aeruginosa | 1 | 2016 | 347 | 0.110 |
Why?
| | Cells, Cultured | 7 | 2020 | 4076 | 0.110 |
Why?
| | Lung | 4 | 2020 | 3926 | 0.110 |
Why?
| | Interleukins | 1 | 2015 | 241 | 0.100 |
Why?
| | Ovalbumin | 2 | 2010 | 178 | 0.100 |
Why?
| | Tuberculosis | 1 | 2015 | 273 | 0.090 |
Why?
| | Mycobacterium tuberculosis | 1 | 2015 | 309 | 0.090 |
Why?
| | Alleles | 2 | 2025 | 845 | 0.090 |
Why?
| | Neutrophils | 1 | 2016 | 1207 | 0.090 |
Why?
| | Retroviridae | 2 | 2013 | 99 | 0.090 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2024 | 704 | 0.090 |
Why?
| | Phosphorylation | 3 | 2020 | 1710 | 0.090 |
Why?
| | Disease Models, Animal | 4 | 2023 | 4057 | 0.090 |
Why?
| | Lung Diseases | 1 | 2016 | 739 | 0.080 |
Why?
| | Lymph Nodes | 3 | 2020 | 470 | 0.080 |
Why?
| | Smoking | 1 | 2016 | 1499 | 0.080 |
Why?
| | Macrophages | 1 | 2016 | 1484 | 0.080 |
Why?
| | NK Cell Lectin-Like Receptor Subfamily B | 2 | 2015 | 10 | 0.070 |
Why?
| | Antigens, Ly | 2 | 2015 | 44 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2020 | 857 | 0.070 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2008 | 220 | 0.070 |
Why?
| | Receptors, CXCR3 | 1 | 2007 | 16 | 0.070 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2007 | 18 | 0.070 |
Why?
| | Receptors, Chemokine | 1 | 2007 | 45 | 0.070 |
Why?
| | Allergens | 1 | 2010 | 384 | 0.070 |
Why?
| | Estrogen Antagonists | 1 | 2007 | 45 | 0.070 |
Why?
| | Cytokines | 2 | 2020 | 2013 | 0.070 |
Why?
| | Tamoxifen | 1 | 2007 | 199 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2022 | 3628 | 0.060 |
Why?
| | Molecular Sequence Data | 2 | 2001 | 2835 | 0.060 |
Why?
| | Peptide Fragments | 1 | 2009 | 692 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 947 | 0.060 |
Why?
| | Skin Transplantation | 1 | 2025 | 84 | 0.060 |
Why?
| | Amino Acid Sequence | 2 | 2016 | 2056 | 0.060 |
Why?
| | Receptors, Estrogen | 1 | 2007 | 426 | 0.060 |
Why?
| | Anaerobiosis | 1 | 2024 | 57 | 0.050 |
Why?
| | Uncoupling Protein 1 | 1 | 2023 | 15 | 0.050 |
Why?
| | Amino Acid Substitution | 1 | 2025 | 282 | 0.050 |
Why?
| | Receptors, Interleukin-12 | 1 | 2003 | 7 | 0.050 |
Why?
| | Bone Marrow Transplantation | 1 | 2025 | 275 | 0.050 |
Why?
| | Heterozygote | 1 | 2024 | 272 | 0.050 |
Why?
| | Immunity, Innate | 3 | 2016 | 803 | 0.050 |
Why?
| | Thermogenesis | 1 | 2023 | 44 | 0.050 |
Why?
| | Receptors, Interleukin | 1 | 2003 | 43 | 0.050 |
Why?
| | Crystallography, X-Ray | 2 | 2018 | 435 | 0.050 |
Why?
| | Adipose Tissue, Brown | 1 | 2023 | 51 | 0.050 |
Why?
| | Crosses, Genetic | 1 | 2003 | 142 | 0.050 |
Why?
| | Receptors, Interferon | 1 | 2023 | 50 | 0.050 |
Why?
| | Respiration | 1 | 2024 | 191 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 1036 | 0.050 |
Why?
| | CD40 Antigens | 1 | 2003 | 88 | 0.050 |
Why?
| | Immunophenotyping | 2 | 2001 | 310 | 0.050 |
Why?
| | Cell Survival | 1 | 2005 | 1074 | 0.050 |
Why?
| | Interleukin-7 | 1 | 2002 | 59 | 0.050 |
Why?
| | Lymphopenia | 1 | 2002 | 60 | 0.050 |
Why?
| | Salmonella typhimurium | 1 | 2024 | 174 | 0.050 |
Why?
| | Homeostasis | 2 | 2004 | 605 | 0.050 |
Why?
| | Humans | 10 | 2024 | 129248 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2022 | 108 | 0.050 |
Why?
| | Clonal Anergy | 1 | 2022 | 51 | 0.050 |
Why?
| | Interferons | 1 | 2023 | 193 | 0.050 |
Why?
| | Protein Conformation | 2 | 2018 | 861 | 0.050 |
Why?
| | Carbohydrate Sequence | 1 | 2001 | 24 | 0.050 |
Why?
| | Antigens, Protozoan | 1 | 2001 | 22 | 0.040 |
Why?
| | Antigens, Fungal | 1 | 2001 | 27 | 0.040 |
Why?
| | Chemokine CCL21 | 1 | 2020 | 14 | 0.040 |
Why?
| | Receptors, CCR7 | 1 | 2020 | 27 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2022 | 588 | 0.040 |
Why?
| | Cell Division | 1 | 2002 | 796 | 0.040 |
Why?
| | Poly I-C | 1 | 2020 | 62 | 0.040 |
Why?
| | Lymphatic System | 1 | 2020 | 11 | 0.040 |
Why?
| | Lectins, C-Type | 1 | 2000 | 71 | 0.040 |
Why?
| | Antigens, Bacterial | 1 | 2001 | 119 | 0.040 |
Why?
| | Antigens, Surface | 1 | 2000 | 151 | 0.040 |
Why?
| | Intestine, Large | 1 | 2000 | 12 | 0.040 |
Why?
| | Dimerization | 1 | 2000 | 191 | 0.040 |
Why?
| | Chemotaxis | 1 | 2020 | 129 | 0.040 |
Why?
| | GTP-Binding Proteins | 1 | 2020 | 158 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2002 | 300 | 0.040 |
Why?
| | Cell Count | 1 | 2020 | 311 | 0.040 |
Why?
| | Polymerization | 1 | 2020 | 123 | 0.040 |
Why?
| | Leukocyte Common Antigens | 1 | 2000 | 82 | 0.040 |
Why?
| | Colon | 1 | 2002 | 252 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 169 | 0.040 |
Why?
| | CD4 Antigens | 1 | 2000 | 138 | 0.040 |
Why?
| | Clone Cells | 1 | 2000 | 262 | 0.040 |
Why?
| | Adipose Tissue | 1 | 2023 | 590 | 0.040 |
Why?
| | Exons | 1 | 2020 | 341 | 0.040 |
Why?
| | Protein Domains | 1 | 2020 | 253 | 0.040 |
Why?
| | Mice, SCID | 1 | 2000 | 350 | 0.040 |
Why?
| | DNA Repair | 1 | 2020 | 206 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2005 | 1688 | 0.040 |
Why?
| | Bleomycin | 1 | 2020 | 242 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2003 | 2703 | 0.040 |
Why?
| | Actins | 1 | 2020 | 411 | 0.040 |
Why?
| | Spleen | 1 | 2000 | 506 | 0.040 |
Why?
| | Immunoglobulin Variable Region | 2 | 2012 | 79 | 0.040 |
Why?
| | Female | 4 | 2020 | 68543 | 0.040 |
Why?
| | Cell Cycle | 1 | 2020 | 589 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2001 | 497 | 0.040 |
Why?
| | Bacteriolysis | 1 | 2016 | 9 | 0.030 |
Why?
| | Amino Acids | 1 | 2020 | 486 | 0.030 |
Why?
| | Base Sequence | 1 | 2020 | 2146 | 0.030 |
Why?
| | Smad1 Protein | 1 | 2016 | 18 | 0.030 |
Why?
| | Activin Receptors, Type II | 1 | 2016 | 11 | 0.030 |
Why?
| | Peroxidase | 1 | 2016 | 174 | 0.030 |
Why?
| | Germ Cells | 1 | 2016 | 59 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2018 | 389 | 0.030 |
Why?
| | Bone Marrow Cells | 2 | 2010 | 302 | 0.030 |
Why?
| | Flow Cytometry | 2 | 2013 | 1155 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 316 | 0.030 |
Why?
| | CRISPR-Cas Systems | 1 | 2016 | 108 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2022 | 1367 | 0.030 |
Why?
| | RNA Splice Sites | 1 | 2015 | 44 | 0.030 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2015 | 44 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2020 | 746 | 0.030 |
Why?
| | Phenotype | 1 | 2023 | 3074 | 0.030 |
Why?
| | Proteins | 1 | 2000 | 941 | 0.030 |
Why?
| | Cell Line | 1 | 2020 | 2779 | 0.030 |
Why?
| | Transgenes | 1 | 2015 | 177 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2020 | 1416 | 0.030 |
Why?
| | Early Growth Response Protein 2 | 1 | 2013 | 10 | 0.030 |
Why?
| | Virulence | 1 | 2015 | 255 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2015 | 161 | 0.030 |
Why?
| | Thymocytes | 1 | 2013 | 34 | 0.030 |
Why?
| | Surface Plasmon Resonance | 1 | 2013 | 88 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2020 | 2374 | 0.030 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2020 | 633 | 0.030 |
Why?
| | Transfection | 1 | 2015 | 915 | 0.030 |
Why?
| | Immune System | 1 | 2013 | 175 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2015 | 389 | 0.020 |
Why?
| | Receptors, Natural Killer Cell | 1 | 2011 | 16 | 0.020 |
Why?
| | Peptides | 1 | 2016 | 923 | 0.020 |
Why?
| | Protein Binding | 1 | 2016 | 2120 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1202 | 0.020 |
Why?
| | Bronchial Hyperreactivity | 1 | 2010 | 105 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2011 | 155 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2010 | 223 | 0.020 |
Why?
| | Adoptive Transfer | 1 | 2010 | 218 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2013 | 1204 | 0.020 |
Why?
| | Crystallization | 1 | 2009 | 138 | 0.020 |
Why?
| | Mutagenesis | 1 | 2009 | 181 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2009 | 525 | 0.020 |
Why?
| | Ligands | 1 | 2010 | 621 | 0.020 |
Why?
| | Intubation, Intratracheal | 1 | 2010 | 239 | 0.020 |
Why?
| | Crystallography | 1 | 2007 | 26 | 0.020 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2007 | 12 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 2007 | 12 | 0.020 |
Why?
| | Receptors, Thyroid Hormone | 1 | 2007 | 21 | 0.020 |
Why?
| | Complementarity Determining Regions | 1 | 2007 | 49 | 0.020 |
Why?
| | Receptors, Retinoic Acid | 1 | 2007 | 51 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2010 | 505 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 297 | 0.020 |
Why?
| | Models, Molecular | 1 | 2011 | 1486 | 0.020 |
Why?
| | Precipitin Tests | 1 | 2004 | 97 | 0.010 |
Why?
| | CpG Islands | 1 | 2004 | 152 | 0.010 |
Why?
| | Time Factors | 1 | 2013 | 6543 | 0.010 |
Why?
| | Organ Culture Techniques | 1 | 2003 | 153 | 0.010 |
Why?
| | Stromal Cells | 1 | 2003 | 105 | 0.010 |
Why?
| | Cloning, Organism | 1 | 2002 | 6 | 0.010 |
Why?
| | Immunoglobulin Joining Region | 1 | 2001 | 10 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2004 | 756 | 0.010 |
Why?
| | Liver | 1 | 2010 | 1839 | 0.010 |
Why?
| | Hematopoietic Stem Cells | 1 | 2004 | 381 | 0.010 |
Why?
| | Cell Lineage | 1 | 2001 | 332 | 0.010 |
Why?
| | Aged | 1 | 2016 | 22032 | 0.010 |
Why?
| | Stem Cells | 1 | 2001 | 574 | 0.010 |
Why?
| | Middle Aged | 1 | 2016 | 31087 | 0.010 |
Why?
| | Male | 1 | 2020 | 63501 | 0.010 |
Why?
| | Aging | 1 | 2002 | 1774 | 0.010 |
Why?
|
|
Matsuda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|